Member Info for Babbler2

couldn't get a quote below 0.4 to buy... typical.

No quotes to buy typical.

Well it's close... Tempted with buy back... But how low will it go? Got to love aim... Star yesterday bad one today...

Decided to take the profit... For now... As too many shorters there. Probably shoot up now. May buy back if goes to 0.37.

9 mil buy just in

all over the place this morning... bulls v bears who will win?

confidentiality means they cant give more details... buys as sells again as can buy around 110... will 130 Year High be seen?

Its pretty much all buys as the MMs closed shop on Sells... :D

0.469 to buy they are NOT sell ;)

buys as sells as usual. crafty MMs...

give up you missed the fekin boat. Live with it and move the fek on.

lol

Not sure about the M as the one in oz actually dropped on news?

ANGS, UJO, OEX and a few others bad bad day today... perhaps they need to put it into FRR ;)

Yes as stated a lot bidding for top fallers today... hope they put it all in FRR lmao...

Marine... usual terrible reporting from them... going into "But shares were tarnished" talking about GGP straight after with no new paragraph making it sound related to FRR... jeez I could write better than that! :D

Will be quite a few contending for top faller today that's for sure... imo

Morning... yes LOTS of news out... nothing stunning... MTR and OPTI perhaps the highlights imo... some others on TGBA...

put my glasses back on now... lmao... "details" not "deals"... back to bed.

very nice... note: "no further deals can be disclosed"... does that mean they can be made but not told to the market?

OptiBiotix will receive a six figure payment from The Company at signing and at two subsequent conditional milestones, amounts totalling a seven-figure sum. An additional six-figure sum, plus royalties on future product sales, are due on product launch. There is an additional seven-figure payment should The Company decide to exercise its option at any point.



The Company requires its identity and the terms of the agreement to remain confidential to protect its commercial interests and no further details can be disclosed. Further announcement will be made in due course.